DXCM

Dexcom Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth 7/10
  • Momentum 4/10
Dexcom sales and earnings growth
DXCM Growth
Good
  • Revenue Y/Y 15.60%
  • EPS Y/Y 46.58%
  • FCF Y/Y 70.79%
Dexcom gross and profit margin trends
DXCM Profitability
Great
  • Gross margin 60.10%
  • EPS margin 17.90%
  • ROIC 22.40%
Dexcom net debt vs free cash flow
DXCM Risk
Great
  • Debt / Equity 0.5
  • Debt / FCF 0.4
  • Interest coverage 60.5

Dexcom stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗